Lv3
380 积分 2022-10-18 加入
Cost-effectiveness analysis of pembrolizumab plus chemotherapy for patients with recurrent or metastatic cervical cancer in China
20小时前
已完结
Camrelizumab Plus Famitinib versus Camrelizumab Alone and Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer: A Randomized, Phase II Study
2个月前
已完结
A Systematic Review of Methodologies Used in Models of the Treatment of Diabetes Mellitus
3个月前
已完结
皖公网安备34019202002308
